Literature DB >> 10999917

Screening and litigation. The rate of interval cancers is too high.

J R Benson, A D Purushotham, R Warren.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10999917      PMCID: PMC1127871     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  The characteristics of false negative cervical smears--implications for the UK cervical cancer screening programme.

Authors:  R W Baker; J P O'Sullivan; J Hanley; D V Coleman
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

2.  Screening for breast and cervical cancer as a common cause for litigation. A false negative result may be one of an irreducible minimum of errors.

Authors:  R M Wilson
Journal:  BMJ       Date:  2000-05-20

3.  Women's understanding of the mammography screening debate.

Authors:  S Woloshin; L M Schwartz; S J Byram; H C Sox; B Fischhoff; H G Welch
Journal:  Arch Intern Med       Date:  2000-05-22

Review 4.  Small cell and 'pale' dyskaryosis.

Authors:  P A Smith; L S Turnbull
Journal:  Cytopathology       Date:  1997-02       Impact factor: 2.073

5.  The role of numeracy in understanding the benefit of screening mammography.

Authors:  L M Schwartz; S Woloshin; W C Black; H G Welch
Journal:  Ann Intern Med       Date:  1997-12-01       Impact factor: 25.391

6.  Previous mammograms in patients with impalpable breast carcinoma: retrospective vs blinded interpretation. 1993 ARRS President's Award.

Authors:  J A Harvey; L L Fajardo; C A Innis
Journal:  AJR Am J Roentgenol       Date:  1993-12       Impact factor: 3.959

7.  Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region.

Authors:  C B Woodman; A G Threlfall; C R Boggis; P Prior
Journal:  BMJ       Date:  1995-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.